# 1. Financial Performance ## A. Key Figures * **Revenue Growth:** **11%** YoY (Q2 FY'26) * **EBITDA Growth:** **16.1%** YoY (Q2 FY'26) · **20.9%** EBITDA margin (+91 bps YoY) * PAT Growth: 19.9% YoY (Q2 FY'26) · EPS of ₹3.26 (vs. ₹2.73 prior) * ROCE: 18.7% (+217 bps YoY) * **Net Debt/EBITDA:** **0.52x** * **Effective Tax Rate:** **25%** (vs. 14% prior quarter) ## B. Revenue Growth * **Strong Underlying Momentum:** Majority of revenue and EBITDA growth driven by **robust operational performance**, with only minor positive FX contribution. * **Growth Quality:** **27% of revenue growth** and **40–45% of EBITDA growth** attributed to core operations, signaling high-quality expansion. ## C. Profitability Trends * **Margin Expansion Continues:** EBITDA margin improved for the fifth consecutive quarter, supported by **scale leverage and mix shift toward high-growth Beauty & Cosmetics**. * **Europe Margin Pressure:** Experienced contraction due to **loss of scale amid top-line softness**, though management highlights **seasonal volatility** in key markets as a mitigating factor. * **Cost Discipline:** Other expenses grew below revenue pace despite strategic investments and inflationary pressures, reflecting **selective spending control**. * **Tax Rate Volatility:** Recent increase in effective tax rate driven by shifts in **geographic earnings mix and intercompany dividends**, not operational changes. ## D. Balance Sheet Strength * **Healthy Leverage Profile:** Net debt/EBITDA at **0.52x** underscores conservative capital structure and strong cash flow generation. * **Capital Efficiency Trajectory:** ROCE has improved nearly **400 bps over two years**, with clear line of sight to **>25% ROCE target by FY '29** through ongoing optimization. --- # 2. Product & Segment Performance ## A. Key Figures * Beauty & Cosmetics Growth: 26.3% YoY (fourth consecutive quarter of double-digit growth) * **Personal Care & Beyond Mix:** **53%** of total revenue * **Sustainable Tube Mix:** **38%** * Regional Growth: 27.4% Americas · 10.6% EAP · 2.8% Europe ## B. Beauty & Cosmetics * **Core Growth Engine:** Beauty & Cosmetics remains a key driver with **sustained double-digit momentum** over recent quarters, supported by innovation and strategic investments like **NEOSeam** and extruded formats. * **Strategic Expansion:** EPL secured site and licenses to begin customer supplies in Q3, accelerating footprint in the high-potential Beauty & Cosmetics market. * **Sustainability Advantage:** With **EcoVadis Platinum rating** and sustainable tube mix at **38%**, the company is well-positioned to capture share from eco-conscious global brands. * **Sales Model Evolution:** A dedicated, agile sales approach is being scaled for Beauty & Cosmetics—distinct from Oral Care’s key account model—to support **ambitions beyond double-digit growth**. ## C. Oral Care * **Recovery Underway:** Oral Care showed Q1 softness but improved in Q2, with stable consumer habits and maintained market share supporting a near-term rebound. * **Innovation Driving Value:** The **tube-in-tube format** continues to deliver strong revenue contribution despite modest volume growth, highlighting premiumization and differentiation. * **Europe Margin Pressure:** Recent margin decline not due to mix or lost orders, but driven by **downstocking from one major customer**, primarily impacting Oral Care. ## D. Regional Performance * **Americas Strength:** Region delivered **broad-based double-digit growth across all countries**, led by Brazil—now the **third-largest global Beauty & Cosmetics market**—where scale remains small but growth runway is substantial. * **EAP Resilience:** Solid 6% growth underpinned by strong Oral and Beauty performance; local teams and innovation driving **higher ASPs** and sustained momentum. * **Europe Challenges & Outlook:** 8% growth constrained by tough prior base and customer-specific downstocking; continued investment in Beauty despite cost pressure reflects long-term strategic focus. * **Brazil Investment Priority:** Viewed as high-growth, high-margin opportunity with **currency risks actively managed**, warranting future resourcing and expansion. --- # 3. Volume & Pricing Trends ## A. ASP Expansion * **ASP-Driven Revenue Growth:** Higher selling prices for innovative tube-in-tube products, underpinned by advanced design, are significantly boosting Oral segment revenue. ## B. Contractual Pricing * **Pricing Model Stability:** Revenue mix of contractual pricing (commodity cost pass-through) and non-contractual pricing (negotiated adjustments) ensures predictable P&L performance. --- # 4. Manufacturing & Capacity ## A. Key Figures * **Capacity Utilization:** 60–65% blended range (peaks trigger modular expansion) · 65–70% in oral care · 50–55% in Beauty & Cosmetics ## B. Thailand Plant * **Rapid Launch Achieved:** New greenfield Thailand plant commenced operations in October, completed in just 9 months, reflecting accelerated execution capability. * **Commercialization Underway:** Commercial billing begins this quarter with gradual ramp-up; **aggressive scaling** planned due to strong pipeline and modular strategy. * **Low-Cost Structure:** Benefits from minimal indirect costs via oversight by EAP leadership in China (2-hour proximity), enabling **low overhead and breakeven point**. * **Margin Trajectory:** Not yet EBITDA-positive and not expected to be in Q3/Q4; projected to become a **very high-margin facility** at scale. ## C. Brazil Expansion * **Strong Regional Performance:** Brazil plant contributing meaningfully to regional growth, with sustained momentum anticipated in this high-potential market. * **Demand-Driven Investment:** No immediate capex planned, but recent line expansion completed; future decisions will be **proactive and volume-based**. * **Limited Financial Drag:** Thailand and Brazil expansions not expected to cause **material EBITDA drain** on company-wide financials. ## D. Utilization & Global Optimization * **Modular Expansion Discipline:** Capacity additions triggered when utilization reaches or exceeds **65%**, with post-peak target to stabilize around optimal levels. * **Tariff-Responsive Manufacturing:** Strategic shifts in production footprint—such as moving **laminates from China to India**—to mitigate tariff impacts. * **US Resilience:** Majority of US value addition occurs domestically via local plant, reducing exposure to international tariff volatility. --- # 5. Cost Structure & Efficiency ## A. Key Figures * **Employee Expenses:** **₹215 Cr** Q1 · **₹233 Cr** Q2 (up from ₹200–205 Cr run rate) ## B. S&D Investments * **Strategic Sales Ramp-Up:** Elevated cost run rate reflects structural investments in frontline sales capabilities, particularly in Beauty & Cosmetics to target **value-added, smaller-volume customers** globally. * **Controlled Hiring Trajectory:** Ongoing sales force additions expected, but no significant near-term step-up planned, indicating disciplined expansion. ## C. Inflation Impact * **Margin Pressure Mismatch:** Despite sequential revenue growth, margin contraction was disproportionate due to **fixed cost absorption issues** and inflation, labeled an **aberration expected to reverse** as volumes normalize. ## D. Cost Philosophy * **Commodity Cycle Resilience:** Active **customer-level gross margin monitoring** enables timely pricing actions to insulate performance from commodity volatility. * **Dynamic Cost Arbitrage:** Manufacturing shifted to **low-cost regions like China** when input prices are favorable, enhancing cost flexibility. * **Disciplined Cost Framework:** Management distinguishes between **"good cost"** (return-generating) and **"bad cost"** (non-value-adding), with commitment to eliminate the latter. --- # 6. Input Cost & Customer Risks ## A. Polymer Price Risk * **Stable Input Costs:** Polymer prices have remained stable over the past two years, though this has not materially boosted margins, which were driven instead by operational efficiencies. * **Pricing Power in Place:** The company has mechanisms to pass through future polymer cost increases, such as a return to 2022 levels, though no quantified impact was provided. * **Lack of Cost Breakdown:** No disclosure was made on the relative cost split between polymer and aluminium inputs. ## B. Customer Destocking * **Europe Margin Pressure:** A major customer’s destocking exercise significantly weighed on European margins and revenue, creating a temporary deviation from the company’s **mid-teens margin guidance** for the region. * **Resilient Regional Fundamentals:** Despite the destocking headwind, underlying performance in Europe remains strong, suggesting the impact is transitory. ## C. Tariff Exposure * **US Tariff Mitigation:** Local US manufacturing insulates EPL from full tariff risk; pricing adjustments and alternative sourcing strategies are being deployed pending final trade rules. * **Persistent Trade Challenges:** Tariff pressures, especially in the US, remain difficult to fully offset despite operational safeguards. --- # 7. Guidance & Outlook ## A. Key Figures * **Full-Year Effective Tax Rate:** **20–22%** (guidance unchanged) ## B. Revenue Forecast * **Europe Recovery in Sight:** Recent revenue decline attributed to short-term destocking, not structural loss; recovery expected in the near term. * **Sustained Growth Trajectory:** Outlook remains robust with guidance for sustainable double-digit revenue growth underpinned by geographical expansion and organic momentum. ## C. Margin Expectations * **EBITDA Growth Outpacing Revenue:** Management guiding for EBITDA growth to exceed revenue growth, supported by margin expansion in Europe as cost structures stabilize. * **Tax Guidance Confirmed:** Full-year tax rate expected to remain within the **20–22%** range, providing predictability for earnings modeling. ## D. Capex Plans * **Capital-Efficient Expansion:** Capex in Thailand and Brazil remains modest, leveraging a creative, cost-efficient plant model and demand-sequenced capacity buildout. * **Strategic Clarity Ahead:** New leadership acknowledges early tenure but commits to delivering a clear strategic plan soon to unlock next-phase growth.